DEF: Lumexa Imaging Holdings Annual Meeting Proxy Statement

Lumexa Imaging Holdings, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, scheduled for June 10, 2026, to elect directors and ratify auditor appointment.

Summary

• Lumexa Imaging Holdings, Inc. is holding its 2026 Annual Meeting of Stockholders virtually on June 10, 2026.
• The meeting will address the election of three Class I directors, the ratification of PricewaterhouseCoopers LLP (PwC) as the independent auditor for the year ending December 31, 2026, and any other business properly brought before the meeting.
• Stockholders of record as of April 13, 2026, are eligible to vote.
• The Board of Directors recommends voting FOR the director nominees and FOR the ratification of PwC.
• Proxy materials are being furnished to stockholders primarily over the internet, with instructions on how to access them and vote provided via a Notice of Internet Availability.
• The company has detailed its corporate governance practices, including board leadership structure, committee functions, and director independence.
• Information on executive compensation for 2025 is provided, including base salary, bonuses, and equity awards.
• The Audit Committee has reviewed the 2025 financial statements and recommended their inclusion in the Annual Report.
• Details on related party transactions, including those related to the IPO and services provided to Holdings LLC, are disclosed.
• The filing also includes information on Section 16(a) reporting compliance and beneficial ownership of common stock.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this filing as neutral to slightly positive, reflecting standard corporate governance procedures and upcoming annual meeting business. While there are no significant negative financial disclosures, the late filing of ownership reports is a minor concern.

Positives

• The company is holding its annual meeting to ensure shareholder participation in corporate governance.
• The Board of Directors is recommending FOR the election of directors and the ratification of the auditor, indicating confidence in current leadership and financial oversight.
• The company is providing clear instructions for virtual attendance and voting, maximizing accessibility for stockholders.
• Detailed information on corporate governance, executive compensation, and related party transactions is being disclosed, promoting transparency.
• The company believes its corporate governance practices promote and enhance accountability and responsibility.

Negatives

• Several officers and directors filed their initial ownership forms (Forms 3) and subsequent ownership change reports (Forms 4) late due to delays in obtaining EDGAR codes following the IPO.
• Ms. Julie Szeker resigned as Chief Legal Officer and Corporate Secretary on March 13, 2026, forfeiting certain equity awards.

Risks

• Broker non-votes may occur in connection with the election of directors (Proposal No. 1) because it is considered a non-routine matter.
• The company has a significant stockholder, Welsh, Carson, Anderson & Stowe XII, L.P., which holds 73.1% of the outstanding common stock, potentially influencing corporate decisions.
• The Stockholders Agreement with WCAS grants WCAS the right to designate a certain number of directors based on its ownership percentage, potentially impacting board composition.
• The company's corporate governance guidelines do not have a fixed policy on separating the Chair of the Board and CEO roles, though the Board believes separate positions are appropriate at this time.

Future Outlook

The filing does not contain specific forward-looking financial guidance. It outlines the agenda for the upcoming annual meeting, including the election of directors and ratification of the auditor, and provides information on corporate governance and executive compensation.

Management Comments

• "We have elected to take advantage of the Securities and Exchange Commission rule that allows us to furnish proxy materials to our stockholders over the Internet."
• "Your vote is important. Whether you plan to attend the meeting or not, please follow the instructions provided in the Notice of Availability or, if applicable, the proxy card you received, to ensure that your shares will be represented and voted at the Annual Meeting."
• "We believe that effective corporate governance is critical to our ability to create long-term value for our stockholders."
• "The Board unanimously recommends that you vote FOR the election of each of the director nominees named above."
• "The Board and the Audit Committee each unanimously recommend that you vote FOR the ratification of the appointment of PwC as the Companys independent registered public accounting firm for the year ending December 31, 2026."

Industry Context

StockSavvy.ai notes that Lumexa Imaging Holdings, Inc. is operating within the healthcare technology sector, specifically focusing on imaging. The proxy statement details the company's governance structure and upcoming annual meeting agenda, which are standard for publicly traded companies in this industry. The election of directors and auditor ratification are critical steps in maintaining investor confidence and regulatory compliance.

Corporate Governance

Related Party Transactions

• Reorganization transactions in connection with the IPO involving conversion of Incentive Units to stock options and shares of common stock.
• Joinder to a registration rights agreement with WCAS and other equity holders.
• Administrative services agreement with Holdings LLC, where Lumexa Imaging provides services at no charge.
• Indemnification agreements with directors and executive officers.
• Payment of $0.4 million to WCAS Management LP for information technology consulting services during 2025.

Stakeholder Impact

• Shareholders: Will vote on director elections and auditor ratification, influencing company leadership and financial oversight. Their voting rights are detailed, and proxy materials are accessible.
• Management: Executive compensation details are provided, aligning with performance and company goals. Some executives have equity awards tied to stock performance.
• Auditors (PwC): Appointment is subject to ratification, indicating shareholder oversight of financial reporting.
• WCAS (Significant Stockholder): Has rights to designate directors, influencing board composition and strategic direction.

Next Steps

• Hold the 2026 Annual Meeting of Stockholders on June 10, 2026.
• Elect three Class I directors.
• Ratify the appointment of PwC as the independent registered public accounting firm for the year ending December 31, 2026.
• File final voting results in a Current Report on Form 8-K within four business days after the Annual Meeting.

Key Dates

Recommendation

This filing is a routine proxy statement for an annual meeting and does not contain new material financial information or strategic shifts that would warrant a buy or sell recommendation. The information presented is standard for corporate governance and shareholder voting. The late filing of some ownership reports is a minor negative, but does not fundamentally alter the company's outlook based on this document alone.

Keywords

Lumexa Imaging Holdings, Proxy Statement, Annual Meeting, DEF 14A, Director Election, Independent Auditor, PwC, Corporate Governance, Executive Compensation, Stockholder Proposals, IPO, Welsh Carson Anderson & Stowe